簡易檢索 / 詳目顯示

研究生: 劉若芸
Ju-yun Liu
論文名稱: PPP2R2B基因遺傳檢測,啟動子記述與單一鹼基多型性分析
Genetic testing, promoter characterization and single nucleotide polymorphisms analysis of the PPP2R2B gene
指導教授: 李桂楨
Lee, Guey-Jen
學位類別: 碩士
Master
系所名稱: 生命科學系
Department of Life Science
論文出版年: 2007
畢業學年度: 95
語文別: 中文
論文頁數: 69
中文關鍵詞: PPP2R2B基因阿茲海默氏症脊髓小腦萎縮症原發性震顫單一鹼基多型性分析CAG三核苷酸重複擴增
英文關鍵詞: PPP2R2B gene, Alzheimer's disease, spinocerebellar ataxia 12, Essential tremor, Single nucleotide polymorphisms analysis, CAG trinucleotide expansion
論文種類: 學術論文
相關次數: 點閱:175下載:3
分享至:
查詢本校圖書館目錄 查詢臺灣博碩士論文知識加值系統 勘誤回報
  • PPP2R2B基因轉譯出一個專一表現在腦部的去磷酸酶PP2A的調控次單位Bβ。當PPP2R2B基因5’端CAG三核苷酸不正常擴增時,會造成第十二型脊髓小腦運動失調症(SCA12),但當抑制PP2A活性時,會使動物腦部Tau蛋白過度磷酸化,出現類阿茲海默氏症的症狀。先前本實驗室研究顯示,PPP2R2B基因上游-870 ~ +23序列可調節基因基礎表現,且台灣阿茲海默氏症患者中PPP2R2B基因5’端啟動子活性較低的(CAG)7等位基因頻率較正常人族群為高(2.8% vs. 0.2%)。本論文延續先前研究,首先擴大正常人及神經性疾病患者PPP2R2B基因CAG三核苷重複的遺傳資料庫,未發現任何擴增的等位基因,但在4位原發性顫抖症(2.0%)及1位舞蹈症(1.1%)患者,觀察到短的(CAG)5~7等位基因。其次分析PPP2R2B基因4 kb啟動子片段上4個單一鹼基多型性與阿茲海默氏症、原發性顫抖症感受性的相關性,各多型性基因型或等位基因在患者與正常人族群間沒有顯著差異,但-3170C/-2923A/-1905T/-428G單套型可能與阿茲海默氏症的感受性相關。在HEK-293、IMR-32細胞中,-4070 ~ +23的遠端啟動子的轉錄活性顯著低於-870 ~ +23近端啟動子,在SK-N-SH、HEK-293、IMR-32細胞中,(CAG)5~7的近端啟動子轉錄活性亦顯著低於(CAG)16者。

    PPP2R2B is a brain-specific regulatory B subunit of protein phosphatase 2A (PP2A), whose activity is shown to be relevant to Alzheimer’s disease (AD) and other tauopathy. PP2A is a major serine/ threonine phosphatase expressed in all eukaryotic cells. It has been suggested that increased PPP2R2B expression due to CAG repeat expansion at the 5’end of the gene may result in spinocerebellar ataxia 12. However, when the expression of PP2A was suppressed, tau protein was hyper-phosphorylated in the brain, which may result in pathology like AD. We screened the PPP2R2B gene CAG repeats distribution in normal controls and in patients with various neurodegenerative diseases. The distribution of the alleles in cases did not differ significantly from that in the controls, and no expanded allele was found in either groups. However, the shorter (CAG)5~7 alleles were over-represented in patients with tremor (2.0%) and chorea (1.1%) compared with that in the controls (0.0%). In addition, a case-control study was conducted to investigate the association of four PPP2R2B promoter single nucleotide polymorphisms (SNPs) with the risk of AD or tremor. Again no significant difference in genotype and allele frequency distribution between cases and controls was observed. However, the more frequent -3170C/-2923A/-1905T/ -428G haplotype was evidently associated with AD (P = 0.019, odds ratio: 5.99; 95% CI: 1.64-38.4). The 4-kb distal fragment displayed significant decrease promoter activity compared to the 0.9-kb proximal fragment in both IMR-32 (85% activity, P = 0.014) and HEK-293 cells (82% activity, P = 0.013). Compared to the common 16-triplet allele, the rare 5~7-triplet alleles give rise to a significant decrease in the expression level in SK-N-SH, IMR-32 and HEK-293 (0.41~0.79, P = 0.000~0.040).

    壹、緒論………………………………………………….........1 貳、研究目的…………………………………................12 參、研究材料與方法………………………..................13 肆、結果…………………………………………………27 伍、討論…………………………………………………………………35 陸、參考文獻與圖表……………………………………………..........41

    侯懿婷。退化性神經疾病:PPP2R2B基因族群遺傳分析及分生研究。 國立台灣師範大學生命科學系九十三學年度碩士論文。2005。
    馮宜欣。TNF-α及IL-1α基因啟動子多型性與台灣帕金森氏症感受性的分子遺傳學研究。國立台灣師範大學生命科學系九十三學年度碩士論文。2006。
    Abecasis GR, Cookson WO. GOLD-graphical overview of linkage disequilibrium. Bioinformatics 2000;16:182-3.
    Bahl S, Virdi K, Mittal U, Sachdeva MP, Kalla AK, Holmes SE, O'Hearn E, Margolis RL, Jain S, Srivastava AK, Mukerji M. Evidence of a common founder for SCA12 in the Indian population. Ann Hum Genet 2005;69:528-34.
    Benito-Leon J, Louis ED. Essential tremor: emerging views of a common disorder. Nat Clin Pract Neurol 2006;2:666-78.
    Bennecib M, Gong CX, Grundke-Iqbal I, Iqbal K. Inhibition of PP-2A upregulates CaMKII in rat forebrain and induces hyperphos- phorylation of tau at Ser 262/356. FEBS Lett 2001;490:15-22.
    Bozzola E, Savasta S, Peruzzi C, Bozzola M, Bona G. Spinocerebellar ataxias in infancy: pathogenesis of potassium and calcium channels' diseases, clinical features and therapeutical approach. Minerva Pediatr 2007;59:149-156.
    Bramblett GT, Goedert M, Jakes R, Merrick SE, Trojanowski JQ, Lee VM. Abnormal tau phosphorylation at Ser396 in Alzheimer’s disease recapitulates development and contributes to reduced microtubule binding. Neuron 1993;10:1089-99.
    Brusco A, Cagnoli C, Franco A, Dragone E, Nardacchione A, Grosso E, Mortara P, Mutani R, Migone N, Orsi L. Analysis of SCA8 and SCA12 loci in 134 Italian ataxic patients negative for SCA1-3, 6 and 7 CAG expansions. J Neurol 2002;249:923-9.
    Capell A, Saffrich R, Olivo JC, Meyn L, Walter J, Grunberg J, Mathews P, Nixon R, Dotti C, Haass C. Cellular expression and proteolytic processing of presenilin proteins is developmentally regulated during neuronal differentiation. J Neurochem 1997;69;2432-40.
    Dagda RK, Zaucha JA, Wadzinski BE, and Strack, S. A developmentally regulated, neuron-specific splice variant of the variable subunit Bbeta targets protein phosphatase 2A to mitochondria and modulates apoptosis. J Biol Chem 2003;278:24976-85.
    David G, Abbas N, Stevanin G, Durr A, Yvert G, Cancel G, Weber C, Imbert G, Saudou F, Antoniou E, Drabkin H, Gemmill R, Giunti P, Benomar A, Wood N, Ruberg M, Agid Y, Mandel JL, Brice A. Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion. Nat Genet 1997;17:65-70.
    Ferringo P, Langan TA, Cohen P. Protein phosphatase 2A1 is the major enzyme in vertebrate cell extracts that dephosphorylates several physiological substrates for cyclin-dependent protein kinases. Mol Biol Cell 1993;4:669-77.
    Fujigasaki H, Verma IC, Camuzat A, Margolis RL, Zander C, Lebre AS, Jamot L, Saxena R, Anand I, Holmes SE, Ross CA, Durr A, Brice A. SCA12 is a rare locus for autosomal dominant cerebellar ataxia: a study of an Indian family. Ann Neurol 2001;49:117-21.
    Goate A, Chartier-Harlin MC, Mullan M, Brown J, Crawford F, Fidani L, Giuffra L, Haynes A, Irving N, James L. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer’s disease. Nature 1991;349:704-6.
    Gong CX, Shaikh S, Wang JZ, Zaidi T, Grundke-Iqbal I, Iqbal K. Phosphatase activity toward abnormally phosphorylated tau: decrease in Alzheimer disease brain. J Neurochem 1995;65:732-8.
    Gong CX, Lidsky T, Wegiel J, Zuck L, Grundke-Iqbal I, Iqbal K. Phosphorylation of microtubule-associated protein tau is regulated by protein phosphatase 2A in mammalian brain. Implications for neurofibrillary degeneration in Alzheimer’s disease. J Biol Chem 2000;275:5535-44.
    Gulcher JR, Jónsson P, Kong A, Kristjánsson K, Frigge ML, Kárason A, Einarsdóttir IE, Stefánsson H, Einarsdóttir AS, Sigurthoardóttir S, Baldursson S, Björnsdóttir S, Hrafnkelsdóttir SM, Jakobsson F, Benedickz J, Stefánsson K. Mapping of a familial essential tremor gene, FET1, to chromosome 3q13. Nat Genet 1997;17:84-7.
    Hardy J. Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci 1997;20:154-9.
    Healy AM, Zolnierowicz S, Stapleton AE, Goebl M, DePaoli-Roach AA, Pringle JR. CDC55, a Saccharomyces cerevisiae gene involved in cellular morphogenesis: identification, characterization, and homology to the B subunit of mammalian type 2A protein phosphatase. Mol Cell Biol 1991;11:5767-80.
    Higgins JJ, Loveless JM, Jankovic J, Patel PI. Evidence that a gene for essential tremor maps to chromosome 2p in four families. Mov Disord 1998;13:972-7.
    Hill WG. Estimation of linkage disequilibrium in randomly mating populations. Heredity 1974;33:229-39.
    Holmes SE, O'Hearn EE, McInnis MG, Gorelick-Feldman DA, Kleiderlein JJ, Callahan C, Kwak NG, Ingersoll-Ashworth RG, Sherr M, Sumner AJ, Sharp AH, Ananth U, Seltzer WK, Boss MA, Vieria-Saecker AM, Epplen JT, Riess O, Ross CA, Margolis RL. Expansion of a novel CAG trinucleotide repeat in the 5’ region of PPP2R2B is associated with SCA12. Nat Genet 1999;23:391-2.
    Holmes SE, Fujigasaki H, O’Hearn E, Antonarakis S, Cooper JK, Callahan C, Hwang J, Gorelick-Feldman D, Verma IC, Saxena R, Durr A, Brice A, Ross CA, Margolis RL. Spinocerebellar ataxia type 12 (SCA12): additional evidence for a causative role of the CAG repeat expansion in PPP2R2B. Am J hum Genet 2000;67:1074.
    Holmes SE, O’Hearn E, Ross CA, Margolis RL. SCA12: an unusual mutation leads to an unusual spinocerebellar ataxia. Brain Res Bull 2001;56:397-403.
    Holmes SE, O’Hearn E, Margolis RL. Why is SCA12 different from other SCAs? Cytogenet Genome Res 2003;100:189-97.
    Ince TA, Scotto KW. A conserved downstream element defines a new class of RNA polymerase II promoters. J Biol Chem 1995;270:30249-52.
    Inzelberg R, Mazarib A, Masarwa M, Abuful A, Strugatsky R, Friedland RF. Essential tremor prevalence is low in Arabic villages in Israel: door-to-door neurological examinations. J Neurol 2006;253:1557-60.
    Jeanneteau F, Funalot B, Jankovic J, Deng H, Lagarde JP, Lucotte G, Sokoloff P. A functional variant of the dopamine D3 receptor is associated with risk and age-at-onset of essential tremor. Proc Natl Acad Sci USA 2006;103:10753-8.
    Jodice C, Mantuano E, Veneziano L, Trettel F, Sabbadini G, Calandriello L, Francia A, Spadaro M, Pierelli F, Salvi F, Ophoff RA, Frants RR, Frontali M. Episodic ataxia type 2 (EA2) and spinocerebellar ataxia type 6 (SCA6) due to CAG repeat expansion in the CACNA1A gene on chromosome 19p. Hum Mol Genet 1997;6:1973-8.
    Kawaguchi Y, Okamoto T, Taniwaki M, Kawaguchi Y, Okamoto T, Taniwaki M, Aizawa M, Inoue M, Katayama S, Kawakami H, Nakamura S, Nishimura M, Akiguchi I. CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Nat Genet 1994;8:221-8.
    Kins S, Kurosinski P, Nitsch RM, Gotz J. Activation of the ERK and JNK signaling pathways caused by neuron-specific inhibition of PP2A in transgenic mice. Am J Pathol 2003;163:833-43.
    Koide R, Kobayashi S, Shimohata T, Koide R, Kobayashi S, Shimohata T, Ikeuchi T, Maruyama M, Saito M, Yamada M, Takahashi H, Tsuji S. A neurological disease caused by an expanded CAG trinucleotide repeat in the TATA-binding protein gene: a new polyglutamine disease? Hum Mol Genet 1999;8:2047-53.
    Koob MD, Moseley ML, Schut LJ, Benzow KA, Bird TD, Day JW, Ranum LP. An untranslated CTG expansion causes a novel form of spinocerebellar ataxia (SCA8). Nat Genet 1999;21:379–84.
    Lahiri DK, Ge YW, Maloney B, Wavrant-De Vrieze F, Hardy J. Characterization of two APP gene promoter polymorphisms that appear to influence risk of late-onset Alzheimer's disease. Neurobiol Aging. 2005 Nov-Dec;26(10):1329-41. Epub 2004 Dec 22.
    Lange-Dohna C, Zeitschel U, Gaunitz F, Perez-Polo JR, Bigl V, Rossner S. Cloning and expression of the rat BACE1 promoter. J Neurosci Res 2003;73:73-80.
    Levy-Lahad E, Wasco W, Poorkaj P, Romano DM, Oshima J, Pettingell WH, Yu CE, Jondro PD, Schmidt SD, Wang K. Candidate gene for the chromosome 1 familial Alzheimer’s disease locus. Science 1995;269:973-7.
    Louis ED, Marder K, Cote L, Pullman S, Ford B, Wilder D, Tang MX, Lantigua R, Gurland B, Mayeux R. Differences in the prevalence of essential tremor among elderly African Americans, whites, and Hispanics in northern Manhattan, NY. Arch Neurol 1995;52:1201-5.
    Louis ED, Fried LP, Fitzpatrick AL, Longstreth WT Jr, Newman AB. Regional and racial differences in the prevalence of physician- diagnosed essential tremor in the United States. Mov Disord 2003;18:1035-40.
    Lv H, Jia L, Jia J. Promoter polymorphisms which modulate APP expression may increase susceptibility to Alzheimer's disease. Neurobiol Aging. 2006 Nov 15.
    Martens E, Stevens S, Janssens J, Gotz J, Goris J, van Hoof C. Genomic organisation, chromosomal localisation, tissue distribution and developmental regulation of the PR61/B’ regulatory subunits of protein phosphatase 2A in mice. J Mol Biol 2004;336:971-86.
    Matsuura T, Yamagata T, Burgess DL, Rasmussen A, Grewal RP, Watase K, Khajavi M, McCall AE, Davis CF, Zu L, Achari M, Pulst SM, Alonso E, Noebels JL, Nelson DL, Zoghbi HY, Ashizawa T. Large expansion of the ATTCT pentanucleotide repeat in spinocerebellar ataxia type 10. Nat Genet 2000;26:191-4.
    Mayer RE, Hendrix P, Cron P, Matthies R, Stone SR, Goris J, Merlevede W, Hofsteenge J, Hemmings BA. Structure of the 55-kDa regulatory subunit of protein phosphatase 2A: evidence for a neuronal-specific isoform. Biochemistry 1991;30:3589-97.
    Nicoletti G, Annesi G, Carrideo S, Tomaino C, Di Costanzo A, Zappia M, Quattrone A. Familial essential tremor is not associated with SCA-12 mutation in southern Italy. Mov Disord. 2002 Jul;17(4):837-8.
    Nyholt DR. A simple correction for multiple testing for singlenucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 2004;74:765-9.
    Overdier DG, Porcella A, Costa RH. The DNA-binding specificity of the hepatocyte nuclear factor 3/forkhead domain is influenced by amino-acid residues adjacent to the recognition helix. Mol Cell Biol 1994;14:2755-66.
    Orr HT, Chung MY, Banfi S, Kwiatkowski TJ Jr, Servadio A, Beaudet AL, McCall AE, Duvick LA, Ranum LP, Zoghbi HY. Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type I. Nat Genet 1993;4:211-26.
    Pei JJ, Gong CX, An WL, Winblad B, Cowburn RF, Grundke-Iqbal I, Iqbal K. Okadaic-acid-induced inhibition of protein phosphatase 2A produces activation of mitogen-activated protein kinases ERK1/2, MEK1/2, and p70 S6, similar to that in Alzheimer's disease.
    Am J Pathol 2003;163:845-58.
    Price NE, Mumby MC. Brain protein serine/threonine phosphatases. Curr Opin Neurobiol 1999;9:336-42.
    Pulst SM, Nechiporuk A, Nechiporuk T, Gispert S, Chen XN, Lopes-Cendes I, Pearlman S, Starkman S, Orozco-Diaz G, Lunkes A, DeJong P, Rouleau GA, Auburger G, Korenberg JR, Figueroa C, Sahba S. Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2. Nat Genet 1996;14:269-76.
    Raiha, I., Kaprio, J., Koskenvuo, M., Rajala, T., Sourander, L., 1996. Alzheimer’s disease in Finnish twins. Lancet 347, 573-578.
    Richard F, Amouyel P. Genetic susceptibility factors for Alzheimer’s disease. Eur J Pharmacol 2001;412:1-12.
    Rogaev EI, Sherrington R, Rogaeva EA, Levesque G, Ikeda M, Liang Y, Chi H, Lin C, Holman K, Tsuda T. Familial Alzheimer’s disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer’s disease type 3 gene. Nature 1995;376:775-8.
    Santoro MF, Annand RR, Robertson MM, Peng Y-W, Brady MJ, Mankovich JA, Hackett MC, Ghayur T, Walter G, Wong WW, Giegel DA. Regulation of protein phosphatase 2A activity by caspase-3 during apoptosis. J biol Chem 1998;273:13119-28.
    Schellenberg GD, Bird TD, Wijsman EM, Orr HT, Anderson L, Nemens E, White JA, Bonnycastle L, Weber JL, Alonso ME. Genetic linkage evidence for a familial Alzheimer’s disease locus on chromosome 14. Science 1992;258:668-71.
    Schmidt K, Kins S, Schild A, Nitsch RM, Hemmings BA, Gotz J. Diversity, developmental regulation and distribution of murine PR55/B subunits of protein phosphatase 2A. Eur J Neurosci 2002;16:2039-48.
    Shahed J, Jankovic J. Exploring the relationship between essential tremor and Parkinson's disease. Parkinsonism Relat Disord. 2007 Mar;13(2): 67-76. Epub 2006 Aug 2. Review.
    Shatunov A, Sambuughin N, Jankovic J, Elble R, Lee HS, Singleton AB, Dagvadorj A, Ji J, Zhang Y, Kimonis VE, Hardy J, Hallett M, Goldfarb LG. Genomewide scans in North American families reveal genetic linkage of essential tremor to a region on chromosome 6p23. Brain 2006;129:2318-31.
    Shenolikar S. Protein serine/threonine phosphatases--new avenues for cell regulation. Annu Rev Cell Biol 1994;10:55-86.
    Shiomi K, Takeichi M, Nishida Y, Nishi Y, Uemura T. Alternative cell fate choice induced by low-level expression of a regulator of protein phosphatase 2A in the Drosophila peripheral nervous system. Development 1994;120:1591-9.
    Sontag E, Nunbhakdi-Craig V, Lee G, Bloom GS, Mumby MC. Regulation of the phosphorylation state and microtubule-binding activity of Tau by protein phosphatase 2A. Neuron 1996 ;17 :1201-7
    Srivastava AK, Choudhry S, Gopinath MS, Roy S, Tripathi M, Brahmachari SK, Jain S. Molecular and clinical correlation in five Indian families with spinocerebellar ataxia 12. Ann Neur 2001;50:796-800.
    Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001;68:978-89.
    Strack S, Zaucha JA, Ebner FF, Colbran RJ, Wadzinski BE. Brain protein phosphatase 2A: developmental regulation and distinct cellular and subcellular localization by B subunits. J Comp Neurol 1998;392:515-27.
    Sulek A, Hoffman-Zacharska D, Bednarska-Makaruk M, Szirkowiec W, Zaremba J. Polymorphism of trinucleotide repeats in non-translated regions of SCA8 and SCA12 genes: allele distribution in a Polish control group. J Appl Genet 2004;45:101-5.
    Thanvi B, Lo N, Robinson T. Essential tremor-the most common movement disorder in older people. Age Ageing 2006;35: 344-9.
    Tsai HF, Liu CS, Leu TM, Wen FC, Lin SJ, Liu CC, Yang DK, Li C, Hsieh M. Analysis of trinucleotide repeats in different SCA loci in spinocerebellar ataxia patients and in normal population of Taiwan. Acta Neurol Scand 2004;109:355-60.
    Turowski P, Myles T, Hemmings BA, Fernandez A, Lamb NJ.
    Vimentin dephosphorylation by protein phosphatase 2A is modulated by the targeting subunit B55. Mol Biol Cell 1999;10:1997-2015.
    Virshup DM. Protein phosphatase 2A: a panoply of enzymes. Curr Opin Cell Biol 2000;12:180-5.
    Wu YR, Lin HY, Chen CM, Gwinn-Hardy K, Ro LS, Wang YC, Li SH, Hwang JC, Fang K, Hsieh-Li HM, Li ML, Tung LC, Su MT, Lu KT, Lee-Chen GJ. Genetic testing in spinocerebellar ataxia in Taiwan: expansions of trinucleotide repeats in SCA8 and SCA17 are associated with typical Parkinson’s disease. Clin Genet 2004;65:209-14.
    Zhuchenko O, Bailey J, Bonnen P, Ashizawa T, Stockton DW, Amos C, Dobyns WB, Subramony SH, Zoghbi HY, Lee CC. Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the 1A-voltage-dependent calcium channel. Nat Genet 1997;15:62-9.

    QR CODE